Przejdź do zawartości
Merck

Przejdź do

OP29

Anti-p53 (Ab-3) (Mutant) Mouse mAb (PAb240)

liquid, clone PAb240, Calbiochem®

Synonim(y):

Mutant p53 Antibody

Zaloguj się, aby wyświetlić ceny organizacyjne i kontraktowe.

Wybierz wielkość

Zmień widok
Gabaryty przesyłkiSKUDostępnośćCena netto
100 μg
Sprawdź dostępność w koszyku
2120,00 zł
200 μg
Sprawdź dostępność w koszyku
2510,00 zł

Informacje o tej pozycji

NACRES:
NA.41
UNSPSC Code:
12352203
Clone:
PAb240, monoclonal
Species reactivity:
mouse, rat, human, chicken, hamster, bovine
Application:
Citations:
19

2120,00 zł


Sprawdź dostępność w koszyku

Zamów zamówienie zbiorcze
Pomoc techniczna
Potrzebujesz pomocy? Nasz zespół doświadczonych naukowców chętnie Ci pomoże.
Pozwól nam pomóc


biological source

mouse

Quality Level

antibody form

purified antibody

antibody product type

primary antibodies

clone

PAb240, monoclonal

form

liquid

contains

≤0.1% sodium azide as preservative

species reactivity

mouse, rat, human, chicken, hamster, bovine

should not react with

Xenopus

manufacturer/tradename

Calbiochem®

storage condition

do not freeze

dilution

(Flow Cytometry (1-20 µg/mL)
Frozen Sections (10 µg/mL)
Gel Shift
Immunoblotting (5 µg/mL)
Immunofluorescence (1-20 µg/mL,
Immunoprecipitation (1 µg per sample)
Paraffin Sections )

isotype

IgG1

shipped in

wet ice

storage temp.

2-8°C

target post-translational modification

unmodified

Gene Information

human ... TP53(7157)

General description

Purified mouse monoclonal antibody generated by immunizing BALB/c mice with the specified immunogen and fusing splenocytes with SP2 mouse myeloma cells (see application references). Recognizes the ~53 kDa mutant p53 protein under non-denaturing conditions. Recognizes both the mutant and the wild-type p53 protein under denaturing conditions.
Recognizes the ~53 kDa mutant p53 protein under non-denaturing conditions by immunoprecipitation, immunofluorescence, and flow cytometry. Recognizes both mutant and wild-type p53 by immunoblotting and paraffin sections under denaturing conditions.
This Anti-p53 (Ab-3) (Mutant) Mouse mAb (PAb240) is validated for use in FC, Frozen Sections, Gel Shift, Immunoblotting, IF, IP, Paraffin Sections for the detection of p53 (Ab-3) (Mutant).

Immunogen

Epitope: within amino acids 213-217
Human
a recombinant protein consisting of amino acids 14-389 of p53 fused to β-galactosidase

Application

Flow Cytometry (1-20 µg/ml)

Frozen Sections (10 µg/ml)

Gel Shift (see comments)

Immunoblotting (5 µg/ml)

Immunofluorescence (1-20 µg/ml, see application references)

Immunoprecipitation (1 µg per sample)

Paraffin Sections (see application references)

Packaging

Please refer to vial label for lot-specific concentration.

Physical form

In 50 mM sodium phosphate buffer, 0.2% gelatin, pH 7.5.

Analysis Note

Negative Control
SK-OV-3 cells
Positive Control
A431, Hs27 (wild-type p53), or SK-BR-3 cells or breast carcinoma tissue

Other Notes

El-Deiry, W.S., et al. 1994. Cancer Res.54, 1169.
Greenblatt, M.S., et al. 1994. Cancer Res.54, 4855.
Barak, Y., et al. 1993. EMBO J.12, 461.
Kastan, M.B., et al. 1992. Cell71, 587.
Kuerbitz, S.J. 1992. Proc. Natl. Acad. Sci. USA89, 7491.
Lane, D.P. 1992. Nature358, 15.
Kastan, M.B., et al. 1991. Cancer Res.51, 6304.
Under non-denaturing conditions (immunoprecipitation, immunofluorescence and frozen sections), Anti-p53 (Ab-3) does not recognize normal (wild-type) p53 protein; it recognizes an epitope exposed by activating mutations or denaturation. In denaturing protocols (immunoblotting and paraffin sections), Anti-p53 (Ab-3) will recognize both mutant and wild-type p53. Will not recognize to some p53 molecules with mutations in the RHSVV epitope, but will react to TFIIIA, which has the RHSVV epitope. For gel shift assay, use Cat. No. OP29L and resuspend in 100 µl buffer. Antibody should be titrated for optimal results in individual systems.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Toxicity: Standard Handling (A)
Ta strona może zawierać tekst przetłumaczony maszynowo.

Porównaj podobne pozycje

Wyświetl pełne porównanie

Pokaż różnice

1 of 1

Ta pozycja
OP140OP03OP09
clone

PAb240, monoclonal

clone

DO-7, monoclonal

clone

PAb421, monoclonal

clone

PAb1801, monoclonal

species reactivity

mouse, rat, human, chicken, hamster, bovine

species reactivity

bovine, monkey, human

species reactivity

rabbit, monkey, human, mouse, rat

species reactivity

human

Gene Information

human ... TP53(7157)

Gene Information

human ... TP53(7157)

Gene Information

human ... TP53(7157)

Gene Information

human ... TP53(7157)

antibody form

purified antibody

antibody form

purified antibody

antibody form

purified antibody

antibody form

purified antibody

biological source

mouse

biological source

mouse

biological source

mouse

biological source

mouse

storage temp.

2-8°C

storage temp.

−20°C

storage temp.

2-8°C

storage temp.

2-8°C


Still not finding the right product?

Explore all of our products under

lub

Wypróbuj nasze narzędzie Narzędzie selektora produktów, aby zawęzić opcje.


Klasa składowania

10 - Combustible liquids

wgk

nwg

flash_point_f

Not applicable

flash_point_c

Not applicable



Certyfikaty analizy (CoA)

Poszukaj Certyfikaty analizy (CoA), wpisując numer partii/serii produktów. Numery serii i partii można znaleźć na etykiecie produktu po słowach „seria” lub „partia”.

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów



Preethi H Gunaratne et al.
Cancer, 125(14), 2409-2422 (2019-04-24)
Over 96% of high-grade ovarian carcinomas and 50% of all cancers are characterized by alterations in the p53 gene. Therapeutic strategies to restore and/or reactivate the p53 pathway have been challenging. By contrast, p63, which shares many of the downstream
Zih-Yin Lai et al.
International journal of molecular sciences, 22(16) (2021-08-28)
As the most common gene mutation found in cancers, p53 mutations are detected in up to 96% of high-grade serous ovarian carcinoma (HGSOC). Meanwhile, mutant p53 overexpression is known to drive oncogenic phenotypes in cancer patients and to sustain the
Tae Won Kwak et al.
OncoTargets and therapy, 10, 137-144 (2017-01-06)
Epigallocatechin-3-gallate (EGCG) is an antioxidant agent derived from green tea. Because it has chemopreventive and anti-invasive effect against various cancer cells, EGCG can be used to inhibit proliferation and invasion of cholangiocarcinoma (CCA) cells. The anticancer effects of EGCG were



Numer pozycji handlu globalnego

SKUNUMER GTIN
OP29-100UG07790788053888
OP29-200UG04055977208429

Questions

  1. For observing the R175H mutant p53, I should not boil/denature my protein samples; is that correct?

    1 answer
    1. Under non-denaturing conditions, such as immunoprecipitation, immunofluorescence, and frozen sections, Anti-p53 (Ab-3) does not recognize normal (wild-type) p53 protein. This antibody recognizes an epitope exposed by activating mutations or denaturation. In denaturing protocols, such as immunoblotting and paraffin sections, Anti-p53 (Ab-3) will recognize both mutant and wild-type p53.

      Helpful?

Reviews

No rating value

Active Filters